In addition, the knockdown of E2F1 was revealed to play a significant role in inhibiting the proliferation, migration, and stemness of CRC cells, indicating that E2F1 may also be a potential therapeutic target for CRC treatment. The gene discussed is E2F1; the disease is colorectal carcinoma.